These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34656708)

  • 41. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical observation of heparin-induced thrombocytopenia].
    Tian HY; Meng Y; Zhang JB; Ma Q; Cheng GS; Fan FL; Wang J; Wan HM
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1405-7. PubMed ID: 19671335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Bersinger S; Lagarde K; Marlu R; Pernod G; Payen JF
    Crit Care Med; 2021 Sep; 49(9):e870-e873. PubMed ID: 34049307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
    Hursting MJ; Soffer J
    Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel oral anticoagulants for heparin-induced thrombocytopenia.
    Skelley JW; Kyle JA; Roberts RA
    J Thromb Thrombolysis; 2016 Aug; 42(2):172-8. PubMed ID: 27102287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
    Ogawa Y; Nagata T; Akiyama T; Nishida K; Kumasawa J; Kohno M; Kohata H; Gohma I
    J Thromb Thrombolysis; 2020 Nov; 50(4):1012-1014. PubMed ID: 32780355
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of a standardized protocol using lepirudin or argatroban for heparin-induced thrombocytopenia.
    Kennedy K; Steinke D; King S; Poe K; Reeves J; Short M
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):262-8. PubMed ID: 21902659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.
    Tanimura K; Ebina Y; Sonoyama A; Morita H; Miyata S; Yamada H
    J Obstet Gynaecol Res; 2012 Apr; 38(4):749-52. PubMed ID: 22380425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review.
    Benken ST; Tesoro EP; Kim KS; Mucksavage JJ
    Neurocrit Care; 2012 Oct; 17(2):177-82. PubMed ID: 22692920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin-induced thrombocytopenia--recognition and treatment.
    Miller PL
    AORN J; 2003 Jul; 78(1):79-86, 89. PubMed ID: 12885069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL; Hursting MJ; McCollum D
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Argatroban: a direct thrombin inhibitor for heparin-induced thrombocytopenia and other clinical applications.
    Chen JL
    Heart Dis; 2001; 3(3):189-98. PubMed ID: 11975790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia.
    Hallman SE; Hebbar L; Robison J; Uber WE
    Anesth Analg; 2005 Apr; 100(4):946-948. PubMed ID: 15781503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.
    Jang IK; Hursting MJ; McCollum D
    Cardiology; 2008; 109(3):172-6. PubMed ID: 17726318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dabigatran as a therapeutic possibility in heparin-induced thrombocytopenia type II].
    Anniccherico FJ; Alonso JL; Urbieta M; Pérez Ricarte S
    An Sist Sanit Navar; 2012; 35(3):521-4. PubMed ID: 23296239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Argatroban use in heparin-induced thrombocytopenia.
    Boggio LN; Oza VM
    Expert Opin Pharmacother; 2008 Aug; 9(11):1963-7. PubMed ID: 18627333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia.
    Gleichgerrcht E; Lim MY; Turan TN
    Neurologist; 2017 Nov; 22(6):241-244. PubMed ID: 29095327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes after heparin-induced thrombocytopenia in patients with Propaten vascular grafts.
    Kasirajan K
    Ann Vasc Surg; 2012 Aug; 26(6):802-8. PubMed ID: 22717356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.